Tugain Solution 10% Cipla — Research Summary
Tugain Solution 10% Cipla is a topical formulation containing minoxidil, a potassium channel opener originally developed for cardiovascular research. This pharmaceutical-grade solution enables researchers to investigate minoxidil’s dual mechanisms of action in both vascular smooth muscle and dermal papilla cell studies. The compound functions as an adenosine triphosphate-sensitive potassium channel agonist, facilitating cellular hyperpolarization and subsequent vasodilation in experimental models. Research applications span from cardiovascular physiology investigations to hair follicle biology studies, where minoxidil’s effects on angiogenesis and cell proliferation provide valuable insights. Our laboratory at Stroid UK Shop maintains strict quality standards for all research chemicals, ensuring consistent experimental outcomes for academic and pharmaceutical research institutions.
Experimental Applications
Minoxidil research encompasses multiple therapeutic pathways, particularly in cardiovascular and dermatological studies. In vascular research, scientists examine minoxidil’s potassium channel activation mechanisms and their effects on smooth muscle relaxation in isolated tissue preparations. The compound’s vasodilatory properties make it valuable for investigating hypertension models and vascular resistance studies. Hair follicle research utilizes minoxidil to study angiogenesis promotion, dermal papilla cell proliferation, and growth factor expression patterns. Researchers also investigate the compound’s effects on prostaglandin synthesis pathways and nitric oxide production in various cell culture systems. The 10% concentration provides optimal strength for dose-response studies and comparative efficacy research. Studies often compare minoxidil with other vasodilators available in our cardiovascular research collection. Advanced researchers frequently combine minoxidil investigations with selective androgen receptor modulators to study synergistic effects on tissue remodeling. Complementary studies may incorporate peptide compounds to examine comprehensive cellular regeneration pathways.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Minoxidil 10% |
| Manufacturer | Cipla |
| CAS Number | 38304-91-5 |
| Molecular Formula | C₉H₁₅N₅O |
| Molecular Weight | 209.25 g/mol |
| Formulation | Topical solution |
| Storage | Room temperature, dry |
| Solvent System | Verify with supplier |
Research Compliance
This product is manufactured by Cipla for in-vitro research applications only. Not intended for human consumption, diagnostic, or therapeutic use. Researchers must follow appropriate laboratory safety protocols and institutional guidelines when handling this research chemical. Store in appropriate laboratory conditions away from heat and moisture.
